PHF5A and neoplasm: First, we analyzed the expression of PHF5A in LUSC patients using both TCGA data sets and our own tumor tissue samples and found that PHF5A was upregulated in LUSC patients but was not significantly correlated with patient outcomes, and this finding differed from those observed in LUAD.